Back to results
TerminatedPhase 3

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

NCT02168920

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Kanto Region, Japan

View on ClinicalTrials.gov
Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type — TrialFind